Table 1.
Patients’ baseline characteristics (n = 1796)
| Variables | Description |
|---|---|
| Age, years | 73 (64, 80) |
| Male, n (%) | 1139 (63.42) |
| BMI, kg/m2 | 24.22 (22.04, 26.87) |
| SBP, mmHg | 130 (116, 142) |
| DBP, mmHg | 80 (70, 86) |
| Heart rate, b.p.m | 75(64, 90) |
| LVEF, % | 50 (40, 59) |
| LVD, mm | 43 (39, 46) |
| NYHA class, n (%) | |
| II | 574 (31.96) |
| III or IV | 1222 (68.04) |
| AF type | |
| Paroxysmal | 274(15.26) |
| Persistent | 39(2.17) |
| Permanent | 1483(82.57) |
| Causes of HF | |
| CHD | 1609(89.59) |
| OMI | 854(47.55) |
| Comorbidities, n (%) | |
| Hypertension | 1131 (62.97) |
| Type II diabetes | 513(28.56) |
| COPD | 432 (24.05) |
| Stroke | 486(27.06) |
| Therapy, n (%) | |
| Beta-blockers | 1213(67.54) |
| ACEI/ARB | 854 (47.55) |
| MRA | 1321(73.55) |
| Loop diuretic | 1252 (69.71) |
| Digitalis | 486 (27.06) |
| Calcium antagonist | 313 (17.43) |
| Anticoagulant | 1646 (91.65) |
| PCI | 365 (20.32) |
| CABG | 110 (6.12) |
| Pacemaker | 62 (3.45) |
| Defibrillator | 7 (0.39) |
| CRT | 6 (0.33) |
BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure, LVEF: Left ventricular ejection fraction, LVD: left atrial dimension, NYHA: New York Heart Association, AF: atrial fibrillation, CHD: coronary heart disease, OMI: old myocardial infarction, COPD: chronic obstructive pulmonary disease, ACEI: angiotensin-converting enzyme inhibitor, ARB: angiotensin receptor blocker, MRA: mineralocorticoid receptor antagonist, PCI: percutaneous coronary intervention, CABG: coronary artery bypass grafting. CRT: Cardiac resynchronization therapy